Literature DB >> 7975267

Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.

Y Becker1.   

Abstract

The published studies on immunization of experimental animals, cattle, and sheep with synthetic peptides containing the antigenic domains in FMDV structural protein VP1 were analyzed. The results obtained with various FMDV synthetic peptides designed to stimulate the humoral immune response in bovines were compared to the current knowledge on MHC class I and class II, and the properties of the peptide binding grooves in each of them. X-ray crystallography of MHC class I proteins provided the three-dimensional structure of the peptide binding groove and led to the isolation and identification of "self" and viral peptides that naturally associate with the peptide binding grooves of both types of MHC and HLA molecules. The available knowledge of the amino acid motifs in MHC and HLA class I-bound viral peptides priming the CD8+ cytotoxic T cell responses must be coupled with the understanding of the three-dimensional structure of BoLA class I. This would aid in the development of an experimental approach to induce bovine anti-FMDV CD8+ cytotoxic cells to complement the humoral immune response to FMDV, which is currently achieved by a killed virus vaccine and, at the experimental level, by a peptide vaccine. Stimulation of both cellular and humoral immune responses against FMDV in cattle may reduce the risk of disease and virus shedding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975267     DOI: 10.1007/BF01703078

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  79 in total

Review 1.  Antigen uptake and presentation by dendritic leukocytes.

Authors:  J M Austyn
Journal:  Semin Immunol       Date:  1992-08       Impact factor: 11.130

2.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.

Authors:  H C Guo; T S Jardetzky; T P Garrett; W S Lane; J L Strominger; D C Wiley
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

Review 3.  Molecular anatomy of viral persistence.

Authors:  M B Oldstone
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Sequence analysis of peptides bound to MHC class II molecules.

Authors:  A Rudensky; P Preston-Hurlburt; S C Hong; A Barlow; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

5.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

6.  Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.

Authors:  Q C Xie; D McCahon; J R Crowther; G J Belsham; K C McCullough
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

7.  On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo.

Authors:  E C McKinney; J W Streilein
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

8.  [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].

Authors:  A Iu Surovoĭ; O M Vol'pina; E V Snetkova; T D Volkova; V T Ivanov
Journal:  Bioorg Khim       Date:  1988-10

9.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

10.  Molecular cloning of bovine class I MHC cDNA.

Authors:  P D Ennis; A P Jackson; P Parham
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

View more
  7 in total

1.  Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Authors:  Fayna Díaz-San Segundo; Marcelo Weiss; Eva Pérez-Martín; Camila C Dias; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

2.  Computer simulations to identify in polyproteins of FMDV OK1 and A12 strains putative nonapeptides with amino acid motifs for binding to BoLA class I A11 and A20 haplotype molecules.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine.

Authors:  Fayna Díaz-San Segundo; Francisco J Salguero; Ana de Avila; M Mar Fernández de Marco; Miguel A Sánchez-Martín; Noemí Sevilla
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Foot and mouth disease virus replication in bovine skin Langerhans cells under in vitro conditions detected by RT-PCR.

Authors:  D David; Y Stram; H Yadin; Z Trainin; Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Interferon-γ induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection.

Authors:  Yooni Oh; Lucy Fleming; Bob Statham; Pip Hamblin; Paul Barnett; David J Paton; Jong-Hyeon Park; Yi Seok Joo; Satya Parida
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

6.  CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle.

Authors:  B Veronica Carr; Eric A Lefevre; Miriam A Windsor; Cristina Inghese; Simon Gubbins; Helen Prentice; Nicholas D Juleff; Bryan Charleston
Journal:  J Gen Virol       Date:  2012-10-03       Impact factor: 3.891

7.  Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1.

Authors:  Chunsheng Yin; Weiye Chen; Qianqian Hu; Zhiyuan Wen; Xijun Wang; Jinying Ge; Qianqian Yin; Haibing Zhi; Chun Xia; Zhigao Bu
Journal:  Vet Res       Date:  2014-06-04       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.